Skip to main content
Published locations for Ensuring optimal adherence to BCR-ABL1 tyrosine kinase inhibitor therapy for chronic myeloid leukemia
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Ensuring optimal adherence to BCR-ABL1 tyrosine kinase inhibitor therapy for chronic myeloid leukemia
User login
Username
Password
Reset your password
/content/ensuring-optimal-adherence-bcr-abl1-tyrosine-kinase-inhibitor-therapy-chronic-myeloid
/jcso/article/75956/leukemia-myelodysplasia-transplantation/ensuring-optimal-adherence-bcr-abl1
/hematology-oncology/article/75956/leukemia-myelodysplasia-transplantation/ensuring-optimal-adherence